Anthony Rizzo, MD
Vascular Surgery · Cleveland, OHNPI 1245294248
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.3%), speaking fees and education — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Abbott at 48.1% of the total. Reporting peaked in 2023 at $6,005 and has fallen 69.7% since, to $1,818 in 2025.
Across 248 payments — averaging $98.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$12K
- Bolton Medical Inc$5K
- Inari Medical, Inc.$2K
- Medtronic$1K
- Intuitive Surgical$1K
- Boston Scientific$712
- plus $3K from 29 others
Across 1 payment — averaging $3496.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$3K
What the payments were for
- Consulting fees$1,9008%
- Speaking & faculty fees$7,65031%
- Travel & lodging$1,9118%
- Food & beverage$10,35742%
- Education$2,64711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 72 | $11,767 |
| Bolton Medical Inc | 34 | $4,819 |
| Inari Medical, Inc. | 6 | $1,556 |
| Medtronic(2 entities) | 20 | $1,221 |
| Intuitive Surgical | 2 | $1,029 |
| Boston Scientific | 31 | $712 |
| Penumbra, Inc. | 4 | $532 |
| Endologix LLC | 4 | $484 |
| Stryker | 8 | $359 |
| W. L. Gore & Associates, Inc. | 11 | $316 |
| Silk Road Medical, Inc. | 2 | $306 |
| Vasorum USA Inc. | 3 | $214 |
| Cook Medical LLC | 4 | $143 |
| Cvrx, Inc. | 2 | $130 |
| Argon Medical Devices, Inc. | 4 | $118 |
| Amgen | 6 | $97 |
| Contego Medical, Inc | 2 | $91 |
| GSK | 3 | $89 |
| Terumo Medical Corporation | 2 | $71 |
| Cardiva Medical, Inc. | 2 | $67 |
| E.r. Squibb & Sons, L.L.C. | 4 | $51 |
| Boehringer Ingelheim | 2 | $35 |
| Surmodics, Inc. | 3 | $35 |
| Philips North America LLC | 2 | $30 |
| Cardiovascular Systems Inc. | 4 | $24 |
| EKOS Corporation | 2 | $24 |
| Novartis | 1 | $24 |
| Novo Nordisk | 1 | $21 |
| Merck | 1 | $18 |
| Shockwave Medical, Inc | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Angiodynamics, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Smith+Nephew | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Supera peripheral stent system$5,720
- SUPERA$3,800
- Relay Grafts$1,866
- Grafts$1,500
- FLOWTRIEVER CATHETER, S$1,430
- CT THROMBECTOMY SYSTEM KIT$1,430
- DAVINCI XI$1,000
- TREO ABDOMINAL STENT-GRAFT SYSTEM$585
- ENROUTE Transcarotid Neuroprotection System$458
- IN.PACT Admiral$355
- ESPRIT$341
- ENROUTE Transcarotid Stent$306
- Indigo System$288
- Heli-FX EndoAnchor System$283
- Relay Plus$281
- Perclose ProGlide suture mediated closure system$260
- JETi All In One Non-Sterile Kit$174
- ENDURANT IIS$169
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$152
- Abre$147
How this compares
$24,464 in reported general payments places this provider in the 85th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 105 | $84,242 |
| XareltoRivaroxaban | 22 | $17,729 |
| Cilostazol | 74 | $1,502 |
| ClopidogrelClopidogrel Bisulfate | 97 | $1,109 |
| Atorvastatin Calcium | 38 | $319 |
| Gabapentin | 44 | $233 |
| Doxycycline Hyclate | 16 | $179 |
| Rosuvastatin Calcium | 11 | $81 |
| Amoxicillin | 15 | $16 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $84,242105 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 213 vascular surgery providers in Ohio.
Other vascular surgery in Cleveland
- Sean LydenCleveland$561K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
- Levester KirkseyCleveland$57K
- Matthew EagletonCleveland$47K
- Jae ChoCleveland$34K
- Ravi AmbaniCleveland$32K
- Benjamin ColvardCleveland$29K
- Daniel McLaughlinCleveland$16K
- Aric WogslandCleveland$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.